Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Spyre Therapeutics Inc., 3 years.
Spyre Therapeutics Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Spyre Therapeutics Inc. June 6, 202387.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 31, 2026 | Rhythm Pharmaceuticals Inc. | Option exercise | +57,187 | $25.79 | $1,474,853 |
| Aug 31, 2026 | Rhythm Pharmaceuticals Inc. | Open-market sale | −23,072 | $104.59 | $2,413,100 |
| Aug 31, 2026 | Rhythm Pharmaceuticals Inc. | Open-market sale | −11,514 | $105.37 | $1,213,230 |
| Aug 31, 2026 | Rhythm Pharmaceuticals Inc. | Open-market sale | −28,188 | $106.20 | $2,993,566 |
| May 18, 2026 | Rhythm Pharmaceuticals Inc. | Option exercise | +3,000 | $17.87 | $53,610 |
| Mar 2, 2026 | Rhythm Pharmaceuticals Inc. | Option exercise | +6,099 | $6.80 | $41,473 |
| Feb 19, 2026 | Rhythm Pharmaceuticals Inc. | Open-market sale | −1,308 | $100.27 | $131,153 |
| Feb 19, 2026 | Rhythm Pharmaceuticals Inc. | Open-market sale | −1,692 | $100.92 | $170,757 |
| Feb 19, 2026 | Rhythm Pharmaceuticals Inc. | Open-market sale | −800 | $102.10 | $81,680 |
| Feb 19, 2026 | Rhythm Pharmaceuticals Inc. | Open-market sale | −585 | $103.28 | $60,419 |
| Feb 17, 2026 | Rhythm Pharmaceuticals Inc. | Open-market sale | −1,200 | $99.42 | $119,304 |
| Feb 17, 2026 | Rhythm Pharmaceuticals Inc. | Open-market sale | −200 | $100.52 | $20,104 |
| Feb 17, 2026 | Rhythm Pharmaceuticals Inc. | Open-market sale | −900 | $101.70 | $91,530 |
| Feb 17, 2026 | Rhythm Pharmaceuticals Inc. | Open-market sale | −1,069 | $103.00 | $110,107 |
| Feb 17, 2026 | Rhythm Pharmaceuticals Inc. | Open-market sale | −200 | $103.84 | $20,768 |
Questions about Hunter C. Smith
What boards is Hunter C. Smith on?
Hunter C. Smith sits on the board of Spyre Therapeutics Inc.
How long has Hunter C. Smith served on boards?
Our records show at least 3 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.